Document is current

Any future updates will be listed below

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

Crossref DOI link: https://doi.org/10.1007/s00280-014-2492-y

Published Online: 2014-05-29

Published Print: 2014-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark